Stay updated on Imvotamab in Non-Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Imvotamab in Non-Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Imvotamab in Non-Hodgkin Lymphoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.2 to version 2.16.3.
    Difference
    0.6%
    Check dated 2025-06-13T16:30:41.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.6%
    Check dated 2025-06-06T10:07:39.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.
    Difference
    2%
    Check dated 2025-05-30T04:54:52.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.0, replacing the previous version 2.15.2.
    Difference
    0.3%
    Check dated 2025-05-23T02:17:26.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    The page has been updated to reflect the submission of results and has been revised to version 2.15.2.
    Difference
    0.2%
    Check dated 2025-05-01T06:25:13.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    The page has undergone significant content changes, including the removal of detailed descriptions of the imvotamab study and its mechanisms, while adding new information about the study's collaborators and a revision number update.
    Difference
    22%
    Check dated 2025-04-16T20:39:35.000Z thumbnail image

Stay in the know with updates to Imvotamab in Non-Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Imvotamab in Non-Hodgkin Lymphoma Clinical Trial page.